Halozyme Therapeutics Inc.

NASDAQ:HALO   3:59:58 PM EDT
40.58
-0.75 (-1.82%)
Products

Halozyme Announces Janssen Receives U.S. FDA Approval Of DARZALEX FASPRO In Combination With Pomalidomide And Dexamethasone

Published: 07/12/2021 12:36 GMT
Halozyme Therapeutics Inc. (HALO) - Halozyme Announces Janssen Receives U.S. FDA Approval of Darzalex Faspro® (daratumumab and Hyaluronidase-fihj) in Combination With Pomalidomide and Dexamethasone for Patients With Multiple Myeloma After First Or Subsequent Relapse.